Recursion Pharmaceuticals (RXRX) Company Statistics | The Fly

Search...

/

Dashboard

Charting

KPIs

Stock Screener

ETF Screener

Earnings Calendar

Events Calendar

Syndicate

Street Research

Portfolios

Alert Settings

© 2026 The Fly Inc.

The Fly Cast

Press play to listen

©

Recursion Pharmaceuticals (RXRX) Company Statistics | The Fly

Recursion Pharmaceuticals

· RXRX

Dashboard

Financials

KPIs

Ratios

Transcripts

Valuation

Statistics

2.161 B

+2.48%

General

Market Cap: $2.16B
Enterprise Value: $1.68B
Shares Outstanding: —
Dividend: —
Employees: —
Revenue Per Employee: —

Fundamental Ratios (TTM)

Gross Margin: -46.66%
Operating Margin: -991.72%
Net Profit Margin: -945.92%
FCF Margin: -645.82%
ROA: -42.79%
ROE: -50.41%
ROIC: -48.34%
Current Ratio: 5.03
Debt-to-Equity: 0.07
Revenue Per Employee: —

Valuation (TTM)

P/E: —
PEG: —
P/S: 39.50
P/FCF: —
P/B: 2.37
EV/EBITDA: -3.79

Growth

Rev 1Y: 26.92%
Rev 1Y Fwd Est: -44.85%
Rev 3Y (CAGR): 23.46%
Rev 5Y (CAGR): 85.36%
Rev 10Y (CAGR): —
EPS 1Y: —
EPS 1Y Fwd Est: —
EPS 3Y (CAGR): —

Income Statement (TTM)

Revenue: $54.86M
Gross Margin: -46.66%
Operating Expenses: $518.41M
Operating Income: -$544.01M
Net Profit: -$518.89M

Balance Sheet

EPS 5Y (CAGR)

—

EPS 10Y (CAGR)

—

Cash and Equivalents: $545.68M
Working Capital: $483.58M
Total Assets: $1.21B
Net Debt: -$483.8M
Total Liabilities: $297.67M
Total Equity: $915M

Cash Flow Statement (TTM)

Cash Flow from Operations: -$350.48M
Cash Flow from Investing: -$6.09M
Cash Flow from Financing: $378.61M
Free Cash Flow: -$354.27M
Capital Expenditures: $3.78M